A Feasibility Study of Weekly Docetaxel with Capecitabine in Ovarian Cancer: A Promising Combination of Two Active Drugs with a Potential for Synergism

Publisher： Karger

E-ISSN： 1421-9794|55|4|298-302

ISSN： 0009-3157

Source： Chemotherapy, Vol.55, Iss.4, 2009-06, pp. : 298-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 126-131

Karger

Access to resources Recommend Favorite

Prospective Study of Vinorelbine and Capecitabine Combination Therapy in Chinese Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

By  

Chemotherapy, Vol. 56, Iss. 4, 2010-08 ,pp. : 340-347

Karger

Access to resources Recommend Favorite

Synergistic Enhancement of Cancer Therapy Using a Combination of Ceramide and Docetaxel

By Feng Li-Xia   Li Min   Liu Yong-Jun   Yang Shao-Mei   Zhang Na  

International Journal of Molecular Sciences, Vol. 15, Iss. 3, 2014-03 ,pp. : 4201-4220

MDPI

Access to resources Recommend Favorite

Low-Dose Weekly Docetaxel Is as Tolerable as Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 147-155

Karger

Access to resources Recommend Favorite

Capecitabine and Cisplatin Combination Is an Active and Well-Tolerated Doublet in the Treatment of Metastatic Breast Carcinoma Patients Pretreated with Anthracycline and Taxanes

By  

Chemotherapy, Vol. 54, Iss. 5, 2008-08 ,pp. : 352-356

Karger

Access to resources Recommend Favorite